Pfizer Inc
PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026Score 11/3053% above fair value
$30.52+0.57 (+1.90%)
Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%
Pfizer DB Geography — United States Revenues by Year
DB Geography — United States Revenues ($M) ($M)
Pfizer DB Geography — United States Revenues: $37,078M in FY2025, down 4.2% from a year earlier.
Latest, FY2025
37,078
Period ended Dec 31, 2025
Change on a year earlier
-4.2%
38,691 in FY2024
History
17 years
Since FY2009
Sources
10
Documents cited below
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-26) ↗
Reported in Database (SEC Form 10-K / 10-Q XBRL via lib/db.py).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | DB Geography — United States Revenues ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 37,078 | -4.2% | Form 10-K (filed 2026-02-26) ↗ |
| FY2024 | Dec 31, 2024 | 38,691 | +37.5% | Form 10-K (filed 2025-02-27) ↗ |
| FY2023 | Dec 31, 2023 | 28,145 | -35.0% | Form 10-K (filed 2025-02-27) ↗ |
| FY2022 | Dec 31, 2022 | 43,317 | +45.6% | Form 10-K (filed 2025-02-27) ↗ |
| FY2021 | Dec 31, 2021 | 29,746 | +38.6% | Form 10-K (filed 2022-02-24) ↗ |
| FY2020 | Dec 31, 2020 | 21,455 | +5.6% | Form 10-K (filed 2022-02-24) ↗ |
| FY2019 | Dec 31, 2019 | 20,326 | +1.0% | Form 10-K (filed 2022-02-24) ↗ |
| FY2018 | Dec 31, 2018 | 20,119 | -22.7% | Form 10-K (filed 2021-02-25) ↗ |
| FY2017 | Dec 31, 2017 | 26,026 | -1.3% | Form 10-K (filed 2018-02-22) ↗ |
| FY2016 | Dec 31, 2016 | 26,369 | +21.5% | Form 10-K (filed 2017-02-23) ↗ |
| FY2015 | Dec 31, 2015 | 21,704 | +13.8% | Form 10-K (filed 2016-02-29) ↗ |
| FY2014 | Dec 31, 2014 | 19,073 | -5.9% | Form 10-K (filed 2015-02-27) ↗ |
| FY2013 | Dec 31, 2013 | 20,274 | -4.9% | Form 10-K (filed 2014-02-28) ↗ |
| FY2012 | Dec 31, 2012 | 21,313 | -15.7% | Form 10-K (filed 2014-02-28) ↗ |
| FY2011 | Dec 31, 2011 | 25,277 | -12.4% | Form 10-K (filed 2014-02-28) ↗ |
| FY2010 | Dec 31, 2010 | 28,855 | +34.0% | Form 10-K (filed 2012-02-28) ↗ |
| FY2009 | Dec 31, 2009 | 21,540 | – | Form 10-K (filed 2012-02-28) ↗ |
Cite this data
StockData. (2026). Pfizer DB Geography — United States Revenues ($M), annual FY2009–FY2025 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/db-geo-rev-us
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.